Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder

Acta Psychiatrica Scandinavica

Volumn 117, Issue 4, 2008, Pages 283-288

  Scherk, H ^a   Backens, M ^b   Schneider Axmann, T ^a   Kemmer, C ^b   Usher, J ^a   Reith, W ^b   Falkai, P ^a   Gruber, O ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Bipolar disorder; Hippocampus; Magnetic resonance spectroscopy; N acetyl aspartate; Thalamus

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHOLINE; CREATINE; INOSITOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN REGION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HYPOTHESIS; MALE; METABOLIC RATE; MOOD DISORDER; NEUROCHEMISTRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; THALAMUS;

ADULT; ASPARTIC ACID; BIPOLAR DISORDER; CHOLINE; CREATINE; DYSTHYMIC DISORDER; FEMALE; HIPPOCAMPUS; HUMANS; INOSITOL; MALE; PUTAMEN; THALAMUS;

EID: 40449096995     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2007.01142.x     Document Type: Article

References (26)

1. Soares JC, Mann JJ. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997 41 : 86 106.
2. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 2003 54 : 515 528.
3. Phillips ML. The neural basis of mood dysregulation in bipolar disorder. Cognit Neuropsychiatry 2006 11 : 233 249.
4. Strakowski SM, Delbello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 2005 10 : 105 116.
5. Scherk H, Reith W, Falkai P. Changes in brain structure in bipolar affective disorders. Nervenarzt 2004 75 : 861 872.
6. Mcdonald C, Zanelli J, Rabe-Hesketh S et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 2004 56 : 411 417.
7. Burtscher IM, Holtas S. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging 2001 13 : 560 567.
8. Bertolino A, Frye M, Callicott JH et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003 53 : 906 913.
9. Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, Tezcan E, Ogur E. Hippocampal 1H MRS in first-episode bipolar I patients. Prog Neuropsychopharmacol Biol Psychiatry 2006 30 : 1235 1239.
10. Deicken RF, Pegues MP, Anzalone S, Feiwell R, Soher B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 2003 60 : 873 882.
11. Blasi G, Bertolino A, Brudaglio F et al. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Psychiatry Res 2004 131 : 95 105.
12. Deicken RF, Eliaz Y, Feiwell R, Schuff N. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Res 2001 106 : 35 45.
13. Moore CM, Breeze JL, Gruber SA et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2000 2 : 207 216.
14. Michael N, Erfurth A, Ohrmann P et al. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology (Berl). 2003 168 : 344 346.
15. Wittchen HU, Zaudig M, Fydrich T. Strukturiertes klinisches Interview für DSM-IV Achse I und II. Göttingen : Hogrefe, 1997.
16. Duvernoy HM. The human brain. Surface, three-dimensional sectional anatomy and MRI: surface, three-dimensional sectional anatomy with MRI and blood supply. Wien : Springer, 1999.
17. Talairach J, Tournoux P. Coplanar stereotaxic atlas of the human brain. New York : Thieme Medical Publishers, 1998.
18. Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005 30 : 1949 1962.
19. 1H MRS). Pharmacopsychiatry 2005 38 : 214 219.
20. Delbello MP, Cecil KM, Adler CM, Daniels JP, Strakowski SM. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2006 31 : 1264 1273.
21. Harte MK, Bachus SB, Reynolds GP. Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol. Schizophr Res 2005 75 : 303 308.
22. Bustillo J, Wolff C, Myers-Y-Gutierrez A et al. Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels. Schizophr Res 2004 66 : 31 39.
23. Bustillo J, Barrow R, Paz R et al. Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. Neuropsychopharmacology 2006 31 : 751 756.
24. Moore GJ, Bebchuk JM, Hasanat K et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000 48 : 1 8.
25. Brambilla P, Stanley JA, Sassi RB et al. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004 29 : 1918 1924.
26. Atmaca M, Yildirim H, Ozdemir H, Ogur E, Tezcan E. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychol Med 2007 37 : 121 129.